HAS THE CELLULAR PROLIFERATION MARKER KI67 ANY CLINICAL RELEVANCE IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK?
- 1 February 1994
- journal article
- Published by Wiley in Clinical Otolaryngology
- Vol. 19 (1), 13-18
- https://doi.org/10.1111/j.1365-2273.1994.tb01140.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Value of grading squamous cell carcinoma of the head and neckHead & Neck, 1992
- Cell cycle gets more cyclinsNature, 1991
- Review: assessment of cell proliferation in histological material.Journal of Clinical Pathology, 1990
- Evolutionary conservation in various mammalian species of the human proliferation-associated epitope recognized by the Ki-67 monoclonal antibody.Journal of Histochemistry & Cytochemistry, 1989
- Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survivalRadiotherapy and Oncology, 1989
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948